Genil Mororó Araújo Camelo

Dr. Genil Mororó Araújo Camelo

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
GCGenil Mororó Araújo Camelo
Genil Mororó Araújo Camelo
JSJeferson Kelvin Silva
Jeferson Kelvin Silva
Stefan GeigerStefan Geiger
Stefan Geiger
MMMaria Norma Melo
Maria Norma Melo
D(Déborah Aparecida Negrão-Corrêa (orientadora)
Déborah Aparecida Negrão-Corrêa (orientadora)
A remarkable characteristic of infectious diseases classified as Neglected Tropical Diseases (NTDs) is the fact that they are mostly transmitted in tropical and subtropical regions with poor conditions of sanitation and low access to healthcare, which makes transmission areas more likely to overlap. Two of the most important NTDs, schistosomiasis and leishmaniasis, despite being caused by very different etiological agents, have their pathogenesis heavily associated with immune-mediated mechanisms, and Schistosoma spp. and Leishmania spp. have been shown to simultaneously infect humans. Still, the consequences of Schistosoma–Leishmania coinfections remain underexplored. As the inflammatory processes elicited by each one of these parasites can influence the other, several changes have been observed due to this coinfection in naturally infected humans, experimental models, and in vitro cell assays, including modifications in susceptibility to infection, pathogenesis, prognostic, and response to treatment. Herein, we review the current knowledge in Schistosoma–Leishmania coinfections in both human populations and experimental models, with special regard to how schistosomiasis affects tegumentary leishmaniasis, discuss future perspectives, and suggest a few steps to further improve our understanding in this model of parasite–host–parasite interaction.

Verified
Journal Article
Open access
PDF file
LMLaura Maggi
Laura Maggi
GCGenil Mororó Araújo Camelo
Genil Mororó Araújo Camelo
IRIzabella Chrystina Rocha
Izabella Chrystina Rocha
WAWilliam Pereira Alves
William Pereira Alves
JMJoão Marcelo Peixoto Moreira
João Marcelo Peixoto Moreira
D(Déborah Aparecida Negrão-Corrêa (orientadora)
Déborah Aparecida Negrão-Corrêa (orientadora)
Schistosoma mansoni eggs retained in host tissues induce innate cytokine release, contributing to the induction of Type-2 immune responses and granuloma formation, important to restrain cytotoxic antigens, but leading to fibrosis. Interleukin(IL)-33 participates in experimental models of inflammation and chemically induced fibrosis, but its role in S. mansoni-induced fibrosis is still unknown. To explore the role of the IL-33/suppressor of the tumorigenicity 2 (ST2) pathway, serum and liver cytokine levels, liver histopathology, and collagen deposition were comparatively evaluated in S. mansoni-infected wild-type (WT) and IL-33-receptor knockout (ST2−/−) BALB/c mice. Our data show similar egg counts and hydroxyproline in the livers of infected WT and ST2−/− mice; however, the extracellular matrix in ST2−/− granulomas was loose and disorganised. Pro-fibrotic cytokines, such as IL-13 and IL-17, and the tissue-repairing IL-22 were significantly lower in ST2−/− mice, especially in chronic schistosomiasis. ST2−/− mice also showed decreased α-smooth muscle actin (α-SMA) expression in granuloma cells, in addition to reduced Col III and Col VI mRNA levels and reticular fibres. Therefore, IL-33/ST2 signalling is essential for tissue repairing and myofibroblast activation during S. mansoni infection. Its disruption results in inappropriate granuloma organisation, partly due to the reduced type III and VI collagen and reticular fibre formation.


18 January 2024 in Parasitology Research
Verified
Journal Article
Closed access
PDF file
JRJoão Gustavo M. Rodrigues
João Gustavo M. Rodrigues
GMGuilherme Silva Miranda
Guilherme Silva Miranda
GCGenil Mororó Araújo Camelo
Genil Mororó Araújo Camelo
VRVanessa Fernandes Rodrigues
Vanessa Fernandes Rodrigues
JSJeferson Kelvin Silva
Jeferson Kelvin Silva
D(Déborah Aparecida Negrão-Corrêa (orientadora)
Déborah Aparecida Negrão-Corrêa (orientadora)

27 April 2025 in Tropical Medicine & International Health
Verified
Journal Article
Open access
GCGenil Mororó Araújo Camelo
Genil Mororó Araújo Camelo
JSJeferson Kelvin Silva
Jeferson Kelvin Silva
DGDharliton Soares Gomes
Dharliton Soares Gomes
LMLaura Maggi
Laura Maggi
Stefan GeigerStefan Geiger
Stefan Geiger
D(Déborah Aparecida Negrão-Corrêa (orientadora)
Déborah Aparecida Negrão-Corrêa (orientadora)
Objectives: Schistosomiasis and tegumentary leishmaniasis simultaneously affect areas in tropical and subtropical regions. Co‐infected individuals show a less‐than‐optimal response to treatment and increased regulatory immune responses. However, no study has determined where Schistosoma–Leishmania co‐infections are more likely to occur.Methods: Data from The Global Health Observatory were collected to determine the worldwide endemicity status of schistosomiasis and tegumentary leishmaniasis in 2023. To determine co‐endemic areas at a local level, an ecological study was conducted on confirmed cases of American tegumentary leishmaniasis and schistosomiasis in the State of Minas Gerais, Brazil, between 2013 and 2017. Local Indicators of Spatial Association analyses were used to search for co‐endemic hotspots.Results: Thirty‐one countries were considered co‐endemic, 23 of which presented active transmission of both diseases. Univariate Local Indicators of Spatial Association indicated 13 municipalities as high–high clusters for both American tegumentary leishmaniasis and schistosomiasis in Minas Gerais. Furthermore, bivariate Local Indicators of Spatial Association analyses identified 61 municipalities as high–high clusters, grouped in seven co‐endemic hotspots.Conclusion: Local Indicators of Spatial Association analyses are a useful tool for identifying areas where co‐infection cases are more likely to occur. Similar analyses will assist authorities and healthcare providers when formulating policies and treating Schistosoma–Leishmania co‐infected patients and will provide valuable data to enable researchers to explore the impact of this and other co‐infections.

Verified
Journal Article
Open access
PDF file
JRJoão Gustavo M. Rodrigues
João Gustavo M. Rodrigues
GMGuilherme Silva Miranda
Guilherme Silva Miranda
GCGenil Mororó Araújo Camelo
Genil Mororó Araújo Camelo
CGCaio Brandão Goes Gouveia
Caio Brandão Goes Gouveia
D(Déborah Aparecida Negrão-Corrêa (orientadora)
Déborah Aparecida Negrão-Corrêa (orientadora)
Strongyloidiasis is a neglected, potentially lifelong disease caused by Strongyloides stercoralis that can lead to a high mortality rate in immunocompromised hosts; therefore, it is necessary to increase the accuracy of infection diagnosis. In the current study, we used Wistar rats experimentally infected with different burdens of Strongyloides venezuelensis to characterize circulating leukocytes and IgM, IgG, IgG1, IgG2a, and IgA reactivity before and after anthelmintic treatment or immunosuppression. Infection, especially with 500 L3, induced an increase in circulating leukocytes, particularly during the acute phase. Animals treated with ivermectin showed complete elimination of the parasite and an early reduction in circulating eosinophils. The production of IgM, IgG, and IgG1 anti-L3 (infective larvae) and anti-Sv (adult worm) antigens was significantly elevated in all infected groups but did not allow differentiation between cured and infected animals. Treatment with dexamethasone delayed worm elimination and temporarily reduced cellular response and parasite-specific IgG production but did not alter IgM reactivity. IgG2a anti-L3 and anti-Sv reactivity showed a progressive reduction, returning to baseline levels in ivermectin-treated rats. IgA anti-ES/L3 (excretory and secretory larval antigens) reactivity significantly decreased in intestinal wash after parasitological cure. These data would help the development of more efficient immunodiagnostic alternatives for human strongyloidiasis based on antibody isotype reactivity.